Ever since the National Institute for Health and Care Excellence (NICE) gave priority to coronary computed tomography angiography (CCTA) as the test of choice for patients presenting with recent-onset ...

After years of declining reimbursement, the US Centers for Medicare & Medicaid Services (CMS) has proposed an increase in the amount paid to hospitals and outpatient clinics for cardiac computed ...

"These extended and sustained benefits appear to be primarily driven by a reduction in the rate of non-fatal MI, suggesting that the principal benefit of CCTA [coronary CT angiography] is driven by ...

An artificial intelligence (AI)-based assessment of coronary CT angiography outperformed visual assessment by human readers and demonstrated superior agreement with a quantitative coronary angiography ...

UK: A machine learning analysis of coronary CT angiography (CCTA) scans has found that skeletal muscle quality may provide ...

Coronary CT angiography for the suspected progression of known coronary artery disease in a 60-year-old female patient. Curved multiplanar reconstructions with 0.6- (yellow outline), 0.4- (blue ...

Elucid, an innovator in AI-powered coronary CT angiography (CCTA) analysis, today announced its largest and most comprehensive presence to date at the Society of Cardiovascular Computed Tomography ...

Please provide your email address to receive an email when new articles are posted on . In patients with stable chest pain and intermediate pretest probability of CAD, risk for major adverse CV events ...

SEATTLE — If you've ever worried about your heart health but scared to undergo an invasive treatment to get it checked, there’s a test that offers answers without a hospital stay or surgery. Dr.

Catalyst MedTech, a leader in nuclear medicine and molecular imaging solutions, today announced a strategic channel partnership with APQ Health to expand access to advanced cardiac CT angiography ...

Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery disease (CAD), allowing for reclassification to a lower disease category in 54% of patients, according ...